News

DermBiont Presents Positive Phase 2 Trial Data Treating Seborrheic Keratosis

Apr 24, 2023
Administrator
0

DermBiont, Inc., a Massachusetts-based corporation developing a skin microbiome therapeutics platform to treat and prevent

Learn More